Home » Topics » BioWorld Science

BioWorld Science
RSS

Wigen Biomedicine Technology presents KRAS mutant inhibitors

July 19, 2021

TYK Medicines divulges new Ret inhibitors

July 19, 2021

GFAP a biomarker in frontotemporal lobar degeneration and primary psychiatric disorders

July 19, 2021

Model of steroid-resistant neutrophilic asthma developed to test treatments

July 19, 2021

New prosthetic valvular graft infection model shows benefit of adjunctive fibrinolytic treatment

July 19, 2021

TGF-beta-mediated mTOR inhibition preserves cellular metabolism of precursors of exhausted T cells

July 19, 2021

HER2 CAR-NK cells show preclinical antitumor activity without off-target cytotoxicity

July 19, 2021

Covimro shows in vivo efficacy in murine model of influenza A H3N2 infection

July 16, 2021

NCCN announces funded research projects to evaluate neratinib in cancer

July 16, 2021

Synlogic begins phase I study of SYNB-1934 for phenylketonuria

July 16, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...